Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Non Operating Income: 2021-2024

Historic Non Operating Income for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -$527,000.

  • Biofrontera's Non Operating Income rose 48.30% to -$365,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $27,000, marking a year-over-year decrease of 99.59%. This contributed to the annual value of -$527,000 for FY2024, which is 120.59% down from last year.
  • As of FY2024, Biofrontera's Non Operating Income stood at -$527,000, which was down 120.59% from $2.6 million recorded in FY2023.
  • Biofrontera's 5-year Non Operating Income high stood at $18.0 million for FY2022, and its period low was -$12.5 million during FY2021.
  • Over the past 3 years, Biofrontera's median Non Operating Income value was $2.6 million (recorded in 2023), while the average stood at $6.7 million.
  • In the last 5 years, Biofrontera's Non Operating Income surged by 244.29% in 2022 and then slumped by 120.59% in 2024.
  • Biofrontera's Non Operating Income (Yearly) stood at -$12.5 million in 2021, then soared by 244.29% to $18.0 million in 2022, then plummeted by 85.76% to $2.6 million in 2023, then crashed by 120.59% to -$527,000 in 2024.